Donor cells with clonal hematopoiesis may improve bone marrow transplant outcomes

Clonal hematopoiesis, a condition in which mutations associated with blood cancers are found in the blood of healthy people, is common with aging.

Related Keywords

Boston ,Massachusetts ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Harvard University ,Dana Farber Cancer Institute ,Richardj Jones ,Lukasz Gondek ,Shiyu Wang ,Emily Henderson ,Elin Zhao ,Christopherd Gocke ,Bryan Hambley ,Amye Dezern ,Rafael Madero Marroquin ,Broad Institute ,Lisa Dynner Fund ,National Institutes Of Health ,Johns Hopkins University School Of Medicine ,Damon Runyon Cancer Research Foundation ,University Of Washington ,Johns Hopkins Kimmel Cancer Center ,Eileen Pasquarello Tissue Bank ,Loisj Champy Family Fund ,Research Fund ,Clinical Oncology ,Johns Hopkins University School ,Massachusetts General Hospital ,National Institutes ,Family Fund ,Bunny Adams Education ,Hematologic Malignancies ,O Reilly Families Cell Manipulation Core ,Bone ,Bone Marrow ,Hematopoiesis ,Transplant ,Aging ,Flood ,Dancer ,Fell ,Cyclophosphamide ,Nmt3a ,Genes ,Hospital ,Leukemia ,Utation ,Ncology ,Prophylaxis ,Research ,Stem Cells ,